long intergenic non-protein coding RNA 2096Genealiases: []
Q-omics provides the consensus-scored LINC02096 profile across patient tissues and cancer cell-line models. LINC02096 expression is associated with patient survival in 10 of 34 cancer types, with the highest sampling consensus in UCEC. Among the 18 cancer types available for tumor–normal comparison, LINC02096 is differentially expressed in 1, with the highest sampling consensus in HNSC. Additionally, LINC02096 RNA expression shows 6,030 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight UCEC, HNSC, and STAD as cancer lineages where LINC02096 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC02096 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC02096 survival associations across molecular data types. LINC02096 RNA expression shows survival associations in the most cancer types (10). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC02096 RNA expression–survival associations across cancer types. High LINC02096 expression shows unfavorable associations in UCEC, BLCA, THCA, OV and GBM, but favorable associations in CESC. The UCEC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify UCEC as the clearest survival context for LINC02096 RNA expression.
This table summarizes LINC02096 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 1. The strongest signals are observed in HNSC for RNA.
This table ranks reproducible tumor–normal expression differences for LINC02096. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC02096 shows higher tumor expression in HNSC. The HNSC box plot shows higher LINC02096 RNA expression in tumor versus normal tissue (log2 FC = +0.033, t-test p = .028).
This table shows molecular features associated with LINC02096 in patient tissues and cancer cell lines. In patient samples, LINC02096 shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.
